# Inflammatory Challenge in Human Aggression.

> **NCT06665074** · PHASE2 · RECRUITING · sponsor: **Ohio State University** · enrollment: 112 (estimated)

## Conditions studied

- Intermittent Explosive Disorder

## Interventions

- **BIOLOGICAL:** Endotoxin (E. coli O:113, Reference Endotoxin)
- **OTHER:** Saline (Placebo)

## Key facts

- **NCT ID:** NCT06665074
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-16
- **Primary completion:** 2029-07
- **Final completion:** 2030-01
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665074, "Inflammatory Challenge in Human Aggression.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06665074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*